Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Somatostatin Analogs and PRRT: Treatment Considerations

January 7th 2019

Peptide Receptor Radionuclide Therapy for NETs

January 7th 2019

Targeted Therapies for the Treatment of NETs

January 7th 2019

Somatostatin Analogs in the Treatment of NETs

January 7th 2019

Surgical Considerations for Patients With NETs

January 7th 2019

Therapies for Controlling Symptoms of NETs

January 7th 2019

Recognizing the Symptoms of NETs

January 7th 2019

Classifying and Treating NETs

January 7th 2019

Accurately Diagnosing NETs

January 7th 2019

The Underlying Biology and Prevalence of NETs

January 7th 2019

Dr. Strickler on the Value of Liquid Biopsies in CRC

January 5th 2019

John Strickler, MD, assistant professor of medicine, Duke University School of Medicine, gastrointestinal oncologist, Duke Cancer Institute, discusses the value of liquid biopsies in the treatment of patients with colorectal cancer (CRC).

Looking for Zebras in Metastatic Colorectal Cancer

January 4th 2019

During a recent OncLive Peer Exchange®, a panel of CRC experts discussed the heterogeneity of metastatic CRC and the need to identify patient subsets within this disease to enable a precision medicine approach.

Pembrolizumab Granted 5 Additional Approvals in Japan

January 3rd 2019

The Japan Pharmaceuticals and Medical Devices Agency has approved pembrolizumab for 5 new indications, including melanoma, advanced microsatellite instability-high tumors, and 3 expanded uses in advanced non–small cell lung cancer.

Dr. Choti Discusses Role of Surgery in Pancreatic Cancer

January 2nd 2019

Michael A. Choti, MD, chief of surgery, Banner MD Anderson Cancer Center, discusses the role of surgery in the treatment of patients with pancreatic cancer.

Dr. O'Connor Discusses Rationale for CORRELATE Trial in mCRC

January 2nd 2019

Juan Manuel O’Connor, MD, head, Department Gastrointestinal Oncology, Department of Clinical Oncology, Institute Alexander Fleming, Buenos Aires, discusses the rationale for the CORRELATE trial in metastatic colorectal cancer.

Challenges Remain With Personalized Medicine in CRC

January 2nd 2019

Pashtoon M. Kasi, MD, MBBS, MS, discusses advances and unmet needs in metastatic colorectal cancer.

Advanced Gastroesophageal Cancer: What Have We Learned, and What's Next

December 29th 2018

Investigators have achieved some success with immune checkpoint inhibitors and antiangiogenesis agents in patients with advanced gastroesophageal cancers, and exciting new agents targeting different tumor growth pathways are under investigation.

Role of Liquid Biopsies Continues to Evolve in GI Cancers

December 29th 2018

Ryan B. Corcoran, MD, PhD, discusses the clinical utility and benefits of liquid biopsies in gastrointestinal cancers.

Pembrolizumab Plus BL-8040 Shows Promise in Pancreatic Cancer

December 29th 2018

Manuel Hidalgo, MD, PhD, discusses the potential with BL-8040 and pembrolizumab in pancreatic adenocarcinoma.

Dr. Bekaii-Saab on Resistance to Targeted Therapy in CRC

December 27th 2018

Tanios Bekaii-Saab, MD, professor of medicine, Mayo Clinic, discusses resistance to targeted therapy in the treatment of patients with colorectal cancer.